Portal de Periódicos da CAPES

Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials

2020; Elsevier BV; Volume: 39; Issue: 3 Linguagem: Inglês

10.1016/j.vaccine.2020.12.016

1873-2518

Vanessa Stevens, Ellyn Russo, Yinong Young‐Xu, Molly Leecaster, Yue Zhang, Chong Zhang, Holly Yu, Bing Cai, Elisa N. Gonzalez, Dale N. Gerding, Jody Lawrence, Matthew H. Samore,

Helicobacter pylori-related gastroenterology studies

Clostridioides difficile infection (CDI) is an important cause of diarrheal disease associated with increasing morbidity and mortality. Efforts to develop a preventive vaccine are ongoing. The goal of this study was to develop an algorithm to identify patients at high risk of CDI for enrollment in a vaccine efficacy trial. We conducted a 2-stage retrospective study of patients aged ≥ 50 within the US Department of Veterans Affairs Health system between January 1, 2009 and December 31, 2013. Included patients had at least 1 visit in each of the 2 years prior to the study, with no CDI in the past year. We used multivariable logistic regression with elastic net regularization to identify predictors of CDI in months 2–12 (i.e., days 31 – 365) to allow time for antibodies to develop. Performance was measured using the positive predictive value (PPV) and the area under the curve (AUC). Elements of the predictive algorithm included age, baseline comorbidity score, acute renal failure, recent infections or high-risk antibiotic use, hemodialysis in the last month, race, and measures of recent healthcare utilization. The final algorithm resulted in an AUC of 0.69 and a PPV of 3.4%. We developed a predictive algorithm to identify a patient population with increased risk of CDI over the next 2–12 months. Our algorithm can be used prospectively with clinical and administrative data to facilitate the feasibility of conducting efficacy studies in a timely manner in an appropriate population.